‘Game-changer’ drug will not be available on NHS
News Previous     Next

‘Game-changer’ drug will not be available on NHS

The Institute of Cancer Research (ICR) has expressed disappointment that the prostate cancer drug abiraterone will not be made available to men with advanced prostate cancer as a first-line treatment on the NHS.

Cancer Nursing Practice. 17, 4,7-7. doi: 10.7748/cnp.17.4.7.s4

You need a subscription to read the full article